Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
Rhea-AI Summary
Tango Therapeutics (NASDAQ: TNGX) announced it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, before U.S. markets open. The company stated it will not host a conference call to discuss the results.
Positive
- None.
Negative
- None.
News Market Reaction – TNGX
In the trading session that priced this news, TNGX declined 1.33%, reflecting a mild negative market reaction. Argus tracked a peak move of +11.8% during that session. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report second quarter 2025 financial results on August 5, 2025, before the open of the U.S. financial markets. The company does not intend to hold a conference call.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:
Elizabeth Hickin
IR@tangotx.com
media@tangotx.com
Source: Tango Therapeutics, Inc.
